封面
市場調查報告書
商品編碼
2018561

膜層析法市場:按形式、膜材料、應用和最終用戶分類-2026-2032年全球市場預測

Membrane Chromatography Market by Format, Membrane Material, Application, End User - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年,膜層析法市場價值將達到 4.6327 億美元,到 2026 年將成長至 5.0969 億美元,到 2032 年將達到 9.5942 億美元,複合年成長率為 10.96%。

主要市場統計數據
基準年 2025 4.6327億美元
預計年份:2026年 5.0969億美元
預測年份 2032 9.5942億美元
複合年成長率 (%) 10.96%

膜層析法的簡明技術和策略概述:概述現代採用因素和操作重點。

在對更高通量、更靈活的生產製造和更高效的製程強化需求的驅動下,膜層析法已從一種小眾的實驗性技術轉變為下游生物製程的核心工具。在過去十年間,開發人員和終端用戶越來越傾向於選擇能夠實現更靈活的生產模式、同時減少面積和週期時間的膜分離形式。因此,該技術如今處於製程工程、材料科學和法規遵循的交匯點,為開發人員、供應商和終端用戶帶來了獨特的機會和挑戰。

材料的進步、一次性解決方案的採用以及製程的整合如何重新定義膜層析法的能力和商業化途徑。

隨著製造商對純化生產線的生產效率、成本效益和適應性提出更高的要求,膜層析法正在發生變革性變化,重塑產業格局。一次性設計和模組化工廠結構因其支援快速換型並避免傳統填充床系統帶來的巨額資本投入,正受到越來越多的關注。同時,膜化學和表面功能化技術的進步正在提升膜的選擇性和動態結合能力,使其能夠應對以往被認為是樹脂分離領域的日益複雜的難題。

2025 年美國關稅趨勢對膜層析法採購、供應商選擇和區域製造策略的影響。

2025年美國關稅環境對膜層析法領域的籌資策略和供應商選擇提出了重大挑戰,尤其是對於透過國際供應鏈採購的組件和耗材而言。關稅措施將改變接收成本,進而影響近岸外包、雙重採購和庫存策略的獎勵。採購團隊和生產負責人正在透過重新評估供應商合約、選擇替代供應商以及權衡短期成本節約和長期供應穩定性來適應這一變化。

詳細的細分分析,將格式選擇、薄膜聚合物、應用要求和最終用戶需求連結起來,指導產品開發和商業化。

細分市場分析揭示了每種規格、材料、應用和最終用戶的不同價值提案,這有助於制定產品開發和市場策略。規格選項包括膠囊配置、可重複使用和一次性使用的卡盒系統以及同樣提供可重複使用和一次性使用的磁碟選項。每種規格都有不同的操作特性。膠囊和卡盒通常可與現有的層析法設備和自動化系統整合,而磁碟則可提供高通量洗脫和緊湊的面積,適用於高速循環操作。一次性使用的卡盒和磁碟可減輕清洗驗證的負擔,並支援大量宣傳活動,而可重複使用的類型可在高運轉率場景下降低每次循環的成本。

區域製造地、法規預期和採購趨勢如何影響全球主要地區膜層析法技術的應用?

區域趨勢對整個膜層析法系統有顯著影響,進而影響技術應用模式、供應商佈局和投資重點。在美洲,終端使用者通常優先考慮快速過渡到臨床試驗和擴大商業規模,這推動了對可實現快速宣傳活動轉換的一次性使用試劑盒和濾盤的需求。此外,該地區成熟的生物製藥中心吸引了供應商投資本地生產和技術支持,從而加快了合格週期,並促進了在製程驗證和監管申報方面的密切合作。

膜層析法供應的競爭趨勢強調透過性能、服務、驗證支援和強大的供應鏈來實現差異化。

競爭考察和供應商分析表明,技術差異化、服務能力和供應鏈韌性是決定市場領導地位的關鍵因素。領先的供應商正在投資可擴展的生產線、擴展技術支援網路並改進文檔,以簡化客戶合格和監管申報流程。與合約研發生產機構 (CDMO) 建立合作夥伴關係以及與配體和樹脂化學供應商建立策略聯盟是加速應用特定解決方案開發和拓展目標應用情境的常見做法。

製造商和供應商的具體策略重點是加速膜層析法的採用、降低合格風險並加強商業性地位。

產業領導企業應採取一系列明確的策略行動,以充分利用膜層析法在生物程序及相關領域日益成長的角色創造價值。首先,調整產品藍圖,使其同時支援一次性使用和可重複使用兩種形式,從而柔軟性適應宣傳活動和連續生產模式。其次,優先投資於膜化學和表面改性,以減少膜污染,提高靶向特異性,同時保持適用於常見滅菌和消毒過程的化學和熱穩定性。

為了確保獲得可操作且檢驗的見解,我們採用嚴格的混合方法,結合技術文獻、相關人員訪談、產品規格分析和政策審查。

本研究採用綜合分析方法,結合技術文獻綜述、相關人員訪談、產品規格分析和政策審查,以確保獲得全面而深入的見解。技術文獻綜述涵蓋同行評審期刊、會議論文集和白皮書,旨在建立材料性能基準,並識別新的膜化學和功能化技術。相關人員訪談對象包括採購經理、製程負責人、品質保證專家和供應商技術專家,旨在了解不同終端使用者場景下的營運需求、挑戰和應用促進因素。

從技術、營運和供應鏈因素如何交織並定義膜層析技術的未來角色這一綜合觀點。

膜層析法正處於一個關鍵的轉折點,材料創新、生產模式轉變和供應鏈重組在此交匯融合,拓展了其在純化工作流程中的實際應用。其應用趨勢將繼續受到以下因素的影響:一次性使用產品的操作柔軟性與可重複使用系統每次循環的經濟性之間的平衡;以及影響抗體純化、疫苗生產和病毒去除等多種應用性能的材料特性。同時,隨著區域製造業投資和關稅趨勢影響供應商策略和採購選擇,供應鏈韌性和驗證支援的重要性也日益凸顯。

目錄

第1章:序言

第2章:調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣,2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章:美國關稅的累積影響,2025年

第7章:人工智慧的累積影響,2025年

第8章:膜層析法市場:依形式分類

  • 膠囊
  • 墨水匣
    • 可重複使用的
    • 一次使用
  • 磁碟
    • 可重複使用的
    • 一次使用

第9章:膜層析法市場(依膜材料分類)

  • 纖維素
  • 尼龍
  • 聚醚碸
  • 聚丙烯
  • PvDF

第10章 膜層析法市場:依應用領域分類

  • 抗體純化
    • 單株抗體
    • 多株抗體
  • 酵素純化
  • 蛋白質純化
  • 疫苗純化
    • 結合疫苗
    • 病毒疫苗
  • 去除病毒和顆粒

第11章 膜層析法市場:依最終用戶分類

  • 學術研究和調查
  • 生物技術
  • 診斷
  • 食品/飲料
  • 製藥

第12章 膜層析法市場:依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章:膜層析法市場:依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 膜層析法市場:依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章:美國膜層析法市場

第16章:中國膜層析法市場

第17章 競爭格局

  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年
  • 3M Company
  • Agilent Technologies Inc
  • Alfa Laval AB
  • Asahi Kasei Corporation
  • Bio-Rad Laboratories Inc
  • Cole-Parmer Instrument Company LLC
  • Danaher Corporation
  • Donaldson Company Inc
  • DuPont de Nemours, Inc.
  • GEA Group AG
  • GVS Group
  • Koch Membrane Systems Inc
  • Merck KGaA
  • Microdyn-Nadir Gmbh
  • Nitto Denko Corporation
  • Novasep Holding SAS
  • Parker Hannifin Corporation
  • Phenomenex
  • Purilogics
  • Repligen Corporation
  • Restek Corporation
  • Sartorius AG
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc
  • Toray Industries Inc
  • TOSOH Corporation
  • Veolia Water Technologies & Solutions
  • Waters Corporation
Product Code: MRR-783E443AFAFC

The Membrane Chromatography Market was valued at USD 463.27 million in 2025 and is projected to grow to USD 509.69 million in 2026, with a CAGR of 10.96%, reaching USD 959.42 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 463.27 million
Estimated Year [2026] USD 509.69 million
Forecast Year [2032] USD 959.42 million
CAGR (%) 10.96%

A concise technical and strategic orientation to membrane chromatography that frames contemporary adoption drivers and operational priorities

Membrane chromatography has shifted from a niche experimental option to a central tool in downstream bioprocessing, driven by demands for higher throughput, flexible manufacturing and improved process intensification. Over the past decade, developers and end users have increasingly favored membrane formats that reduce footprint and cycle time while enabling more agile production paradigms. As a result, the technology now sits at the intersection of process engineering, materials science and regulatory compliance, creating a unique set of opportunities and constraints for developers, suppliers and end users.

This introduction outlines the technological foundations, adoption vectors and operational rationales that underpin membrane chromatography today. It explains how differences in format, membrane polymers and intended application shape performance characteristics and operational models. In doing so, it frames the subsequent sections that examine macro shifts, tariff impacts, segmentation dynamics, regional implications and competitive positioning. The aim is to provide an accessible yet technically grounded overview that supports strategic decisions without presupposing prior expertise in chromatography engineering.

How advances in materials, single use adoption, and process intensification are redefining membrane chromatography capability and commercial pathways

Transformative shifts are reshaping the membrane chromatography landscape as manufacturers seek higher productivity, cost efficiency and adaptability in their purification trains. Single-use philosophies and modular plant architectures are accelerating interest in formats that support quick changeovers and avoid the capital intensity of traditional packed-bed systems. Concurrently, advances in membrane chemistries and surface functionalization are improving selectivity and dynamic binding capacity, allowing membranes to address increasingly challenging separations once considered the purview of resins.

Moreover, industry-wide commitments to sustainability and reduced water usage are influencing material selection and process design. Process intensification strategies, such as continuous downstream processing and integrated upstream-downstream flows, are creating new application niches for membrane systems that can cope with higher flux and shorter residence times. Regulatory trends emphasize process understanding and robust control strategies, prompting suppliers and users to prioritize traceability, single-use validation, and scalable cleaning or replacement protocols. These technological and regulatory inflections are converging to broaden membrane chromatography's role across biologics purification, viral clearance, and other critical separations.

Implications of the United States tariff landscape in 2025 on procurement, supplier qualification, and regional manufacturing strategies for membrane chromatography

The United States' tariff environment for 2025 introduces a material consideration for procurement strategies and supplier selection in membrane chromatography, particularly for components and consumables sourced across international supply chains. Tariff measures alter landed costs, which in turn influence incentives for nearshoring, dual sourcing and inventory strategies. Procurement teams and manufacturing planners are adapting by reassessing supplier contracts, qualifying alternate vendors, and considering the trade-offs between immediate cost mitigation and longer-term supply security.

Beyond pricing impacts, tariff-induced shifts can alter supplier development roadmaps. Vendors may prioritize local manufacturing or strategic partnerships to preserve competitiveness, while buyers might accelerate qualification of domestic production equivalents to minimize exposure. In parallel, regulatory and quality assurance functions must ensure that any supplier transition maintains validation integrity, qualification data and change control documentation. Consequently, tariff dynamics are not merely economic levers; they are catalysts for reshaping supply chains, accelerating regional manufacturing investments, and influencing the pace at which new membrane materials and formats are adopted in regulated environments.

In-depth segmentation analysis linking format choices, membrane polymers, application demands and end-user requirements to guide product development and commercialization

Segmentation insights reveal differentiated value propositions across format, material, application and end user, informing tailored product development and go-to-market strategies. Format choices include capsule configurations, cartridge systems available in both reusable and single-use designs, and disk options that likewise span reusable and single-use executions. Each format presents distinct operational attributes: capsules and cartridges often integrate with existing chromatography skids and automation, while disks can offer high-throughput elutions and compact footprints suitable for rapid cycle operations. Single-use cartridges and disks reduce cleaning validation burdens and support campaign-based manufacturing, whereas reusable variants can deliver lower per-cycle cost in high-utilization scenarios.

Material selection remains a primary determinant of performance and process fit, with cellulose, nylon, polyethersulfone, polypropylene and PVDF membranes each displaying unique combinations of mechanical strength, chemical compatibility and surface chemistry amenable to different ligands. These materials influence factors such as fouling propensity, pressure tolerance and compatibility with sanitization regimes. Application-driven requirements further refine selection: antibody purification activities, split between monoclonal and polyclonal antibody workflows, demand high selectivity and consistent binding; enzyme and protein purification processes emphasize activity retention and gentle elution conditions; vaccine purification, whether for conjugate or viral platforms, prioritizes pathogen clearance and aggregate control; and virus and particle clearance workflows require robust validation and high removal efficiency. End-user contexts, including academic and research labs, biotechnology firms, diagnostics manufacturers, food and beverage processors and pharmaceutical companies, impose divergent demands for throughput, cost sensitivity and regulatory rigor, which in turn shape purchasing behavior and qualification timelines.

Taken together, these segmentation layers create a multidimensional view of demand: format and material choices are traded off against application-specific performance requirements and end-user constraints. Strategic product design therefore benefits from modular offerings that can be configured to meet specific combinations of material compatibility, format preference and application validation needs, allowing suppliers to address both early-stage research customers and mature, regulated production sites.

How regional manufacturing hubs, regulatory expectations, and procurement dynamics shape membrane chromatography adoption across major global territories

Regional dynamics materially influence technology adoption patterns, supplier presence and investment priorities across the membrane chromatography ecosystem. In the Americas, end users often prioritize speed to clinic and commercial scale-up, driving demand for single-use cartridges and disks that support rapid campaign turnover. The region's established biopharmaceutical hubs also attract suppliers that invest in local production and technical support, accelerating qualification cycles and enabling closer collaboration on process validation and regulatory submissions.

Across Europe, the Middle East & Africa, regulatory harmonization and a strong emphasis on manufacturing quality push buyers toward solutions with proven track records and extensive validation datasets. Here, reusable formats can remain attractive where high-volume, continuous operations justify investment in cleaning and validation programs, while selective adoption of single-use elements supports flexibility in clinical-stage manufacturing. The Asia-Pacific region exhibits a blend of rapidly expanding biotech capacity and diverse regulatory environments; local manufacturing investment and government-backed industrialization strategies are expanding demand for membrane systems compatible with high-throughput and cost-sensitive operations. In all regions, logistics considerations, tariff regimes, and local supplier ecosystems shape procurement strategies and the pace at which new membrane chemistries and formats are adopted.

Competitive supply-side trajectories emphasizing differentiation through performance, service, validation support, and resilient supply chains in membrane chromatography

Competitive and supplier insights point to a landscape where technological differentiation, service capability and supply chain resilience determine market leadership. Leading suppliers are investing in scalable manufacturing lines, expanded technical support networks, and enhanced documentation to streamline customer qualification and regulatory filing processes. Partnerships with contract development and manufacturing organizations, as well as strategic collaborations with ligand and resin chemistry providers, are common mechanisms for accelerating application-specific solutions and expanding addressable use cases.

Product portfolios are diversifying to include modular offerings that combine different membrane materials and formats to meet specific operational profiles. Suppliers who can demonstrate reproducible performance across multiple production scales, provide robust validation packages, and offer flexible commercial terms for consumables and replacement modules are increasingly favored by end users. Moreover, companies that invest in digital tools for process monitoring, real-time analytics and predictive maintenance enhance supplier differentiation by reducing operational risk and improving process understanding. As a result, the competitive environment rewards integrated solutions that pair high-performance membranes with comprehensive technical support and resilient supply chain practices.

Actionable strategic priorities for manufacturers and suppliers to accelerate adoption, de-risk qualification, and strengthen commercial positioning in membrane chromatography

Industry leaders should pursue a clear set of strategic actions to capture value from membrane chromatography's expanding role in bioprocessing and related sectors. First, align product roadmaps to support both single-use and reusable formats, enabling flexibility across campaign-based and continuous manufacturing models. Prioritize investments in membrane chemistries and surface modifications that reduce fouling and enhance target specificity while maintaining chemical and thermal stability compatible with typical sanitization regimes.

Second, enhance supply chain resilience through regional manufacturing, dual sourcing and transparent lead-time commitments, especially in light of evolving tariff structures and geopolitical uncertainty. Third, strengthen validation and regulatory support offerings to accelerate customer qualification and reduce adoption friction; comprehensive validation packages, comparability datasets and application notes will be persuasive for regulated end users. Fourth, collaborate closely with end users and CDMOs to co-develop application-specific solutions and demonstration runs that reduce the perceived risk of technology transitions. Finally, leverage digital tools and analytics to offer process monitoring, lifetime performance tracking and predictive maintenance capabilities that create stickiness and deliver measurable operational benefits to customers.

A rigorous mixed-methods approach combining technical literature, stakeholder interviews, product specification analysis, and policy review to ensure actionable and validated insights

This research synthesis employs a methodological framework that integrates technical literature review, stakeholder interviews, product specification analysis, and policy review to ensure robust, multi-angle insights. The technical literature review encompassed peer-reviewed journals, conference proceedings and white papers to establish material performance baselines and identify emerging membrane chemistries and functionalization techniques. Stakeholder interviews included procurement leads, process development scientists, quality assurance professionals and supplier technical experts to capture operational imperatives, pain points and adoption drivers across diverse end-user contexts.

Product specification analysis compared publicly available performance metrics, chemical compatibilities and validation support materials across representative suppliers to identify commonalities and differentiation areas. Policy and tariff reviews examined publicly available regulatory guidance and trade announcements to assess potential impacts on procurement and supply chain decisions. Throughout the study, triangulation was employed to reconcile differing perspectives, and findings were validated through follow-up expert consultations to refine conclusions and ensure practical relevance for decision makers.

Consolidated perspective on how technological, operational, and supply chain forces intersect to define the future role of membrane chromatography

Membrane chromatography stands at a pivotal moment where materials innovation, shifting production paradigms and supply chain realignments converge to expand its practical role in purification workflows. Adoption will continue to be shaped by the balance between operational flexibility offered by single-use formats and the per-cycle economics of reusable systems, as well as by the material properties that dictate performance across diverse applications such as antibody purification, vaccine processing and virus clearance. In parallel, regional manufacturing investments and tariff dynamics will influence supplier strategies and procurement choices, underscoring the importance of supply chain resilience and validation support.

Looking ahead, stakeholders who integrate materials science advances with pragmatic commercialization strategies-prioritizing validation, regionalized supply chains and digital enablement-will be best positioned to capture value. The convergence of technological capability and pragmatic operational design points to an era in which membrane chromatography is increasingly considered a mainstream tool for efficient, high-throughput and flexible downstream processing across biologics and broader industrial applications.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Membrane Chromatography Market, by Format

  • 8.1. Capsule
  • 8.2. Cartridge
    • 8.2.1. Reusable
    • 8.2.2. Single Use
  • 8.3. Disk
    • 8.3.1. Reusable
    • 8.3.2. Single Use

9. Membrane Chromatography Market, by Membrane Material

  • 9.1. Cellulose
  • 9.2. Nylon
  • 9.3. Polyethersulfone
  • 9.4. Polypropylene
  • 9.5. Pvdf

10. Membrane Chromatography Market, by Application

  • 10.1. Antibody Purification
    • 10.1.1. Monoclonal Antibody
    • 10.1.2. Polyclonal Antibody
  • 10.2. Enzyme Purification
  • 10.3. Protein Purification
  • 10.4. Vaccine Purification
    • 10.4.1. Conjugate Vaccine
    • 10.4.2. Viral Vaccine
  • 10.5. Virus And Particle Clearance

11. Membrane Chromatography Market, by End User

  • 11.1. Academic And Research
  • 11.2. Biotechnology
  • 11.3. Diagnostics
  • 11.4. Food And Beverage
  • 11.5. Pharmaceutical

12. Membrane Chromatography Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Membrane Chromatography Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Membrane Chromatography Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Membrane Chromatography Market

16. China Membrane Chromatography Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 3M Company
  • 17.6. Agilent Technologies Inc
  • 17.7. Alfa Laval AB
  • 17.8. Asahi Kasei Corporation
  • 17.9. Bio-Rad Laboratories Inc
  • 17.10. Cole-Parmer Instrument Company LLC
  • 17.11. Danaher Corporation
  • 17.12. Donaldson Company Inc
  • 17.13. DuPont de Nemours, Inc.
  • 17.14. GEA Group AG
  • 17.15. GVS Group
  • 17.16. Koch Membrane Systems Inc
  • 17.17. Merck KGaA
  • 17.18. Microdyn-Nadir Gmbh
  • 17.19. Nitto Denko Corporation
  • 17.20. Novasep Holding S.A.S
  • 17.21. Parker Hannifin Corporation
  • 17.22. Phenomenex
  • 17.23. Purilogics
  • 17.24. Repligen Corporation
  • 17.25. Restek Corporation
  • 17.26. Sartorius AG
  • 17.27. Shimadzu Corporation
  • 17.28. Thermo Fisher Scientific Inc
  • 17.29. Toray Industries Inc
  • 17.30. TOSOH Corporation
  • 17.31. Veolia Water Technologies & Solutions
  • 17.32. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MEMBRANE MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MEMBRANE CHROMATOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MEMBRANE CHROMATOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CELLULOSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CELLULOSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CELLULOSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY POLYETHERSULFONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY POLYETHERSULFONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY POLYETHERSULFONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY PVDF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY PVDF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY PVDF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MONOCLONAL ANTIBODY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MONOCLONAL ANTIBODY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY POLYCLONAL ANTIBODY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY POLYCLONAL ANTIBODY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY POLYCLONAL ANTIBODY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ENZYME PURIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ENZYME PURIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ENZYME PURIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY PROTEIN PURIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY PROTEIN PURIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY PROTEIN PURIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CONJUGATE VACCINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CONJUGATE VACCINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CONJUGATE VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VIRAL VACCINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VIRAL VACCINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VIRAL VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VIRUS AND PARTICLE CLEARANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VIRUS AND PARTICLE CLEARANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VIRUS AND PARTICLE CLEARANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ACADEMIC AND RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ACADEMIC AND RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ACADEMIC AND RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. GCC MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GCC MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 173. GCC MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 174. GCC MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, 2018-2032 (USD MILLION)
  • TABLE 175. GCC MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 176. GCC MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. GCC MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 178. GCC MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 179. GCC MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. G7 MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. G7 MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 200. G7 MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 201. G7 MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, 2018-2032 (USD MILLION)
  • TABLE 202. G7 MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 203. G7 MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. G7 MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 205. G7 MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 206. G7 MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. NATO MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. NATO MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 209. NATO MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 210. NATO MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, 2018-2032 (USD MILLION)
  • TABLE 211. NATO MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. NATO MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. NATO MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 214. NATO MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 215. NATO MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES MEMBRANE CHROMATOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA MEMBRANE CHROMATOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY DISK, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY ANTIBODY PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY VACCINE PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA MEMBRANE CHROMATOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)